Neyret Group showing inhalation medical device assembly capabilities at DDL conference

Chaponost, France: – Neyret Group, the leading manufacturer of customized automatic assembly and test machinery for the medical and life sciences industries, is returning to the Drug Delivery to the Lungs (DDL) Conference in the Scottish capital of Edinburgh as an exhibitor and sponsor.

Neyret Group attended DDL for the first time last year and will once again showcase its advanced capabilities for automated high-speed assembly of inhaler medical devices.

Respiratory medical devices

The Neyret Group exhibition stand at Booth 105 at the Edinburgh International Conference Centre will show a range of respiratory medical devices and their components assembled on Neyret Group platforms, including MDI metered dose inhalers, DPI dry powder inhalers, nasal sprays, Uni-Dose and Bi-dose sprays, Metered aerosol valves, dose counter wheel indicators printed with pad and digital technologies.

A/V displays on stand will feature videos of Neyret’s indexed motion and continuous machines in action, performing multiple precision assembly steps at up to 14,400 units per hour.

High speed assembly

Neyret Group will be represented in Edinburgh by its CEO, Bruno Neyret, and Sales Director Pascal Vansse.

Mr. Neyret commented: “We are very pleased to be returning to DDL, which we have discovered to be an excellent platform for reconnect with our major clients and presenting our know-how to pharma companies looking for high-speed assembly, labelling and printing solutions.”

Neyret’s sister company CB Automation will also be present at DDL 2023, exhibiting its medical and parenteral delivery device and integrated data solutions from Booth 158.

About Neyret Group

French-based Neyret Group, with a worldwide presence, designs and manufactures customized automatic assembly and test machines for the medical and life sciences industries.

The company produces indexed motion and continuous motion assembly, test and print machines that are fully customized to customer’s ideal requirements.

Neyret Group employs more than 270 people at three production sites: in France with Société Guy Neyret producing indexed machines in Chaponost, near Lyon, and Lagniel, producing continuous motion machines in Douvres-la-Délivrande near Caen, Normandy; and in the United States with Franklin Automation producing indexed machines in Sugar Grove, Illinois.

Further information at: https://www.neyretgroup.com

About DDL 2024

The Drug Delivery to the Lungs (DDL) Conference has become one of the world’s premier International Pulmonary and Nasal Drug Delivery events, providing an annual forum for scientists, academics, clinicians, regulatory and industry specialists involved in developing medicines for inhalation.

The 35th anniversary meeting, DDL 2024, is again a three-day event opening December 11 at the Edinburgh International Conference Center at The Exchange close to University of Edinburgh.

The 2024 conference will feature five themed sessions each with a combination of invited and submitted lectures given by experts in inhalation and students working to advance respiratory science. Major themes will include transition to new propellants, developments in inhalation technology, and advances in nasal drug delivery.

The event is organized by The Aerosol Society, with more information at: https://ddl-conference.com

Resources

Click on Neyret technology medical and pharma applications for more on Neyret Group solutions.
Click on Drug Delivery to the Lungs (DDL) Conference 2024 for more information.